Skip to main content

Al B. Benson III, MD, FACP, FASCO

Authored Items
Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors
Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO
November 2017 Vol 10, No 8 in Original Research, Practice Management
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate
Al B. Benson III, MD, FACP, FASCO, Elizabeth Brown, MD
February 2008, Vol 1, No 1 in Practice Management
Last modified: April 23, 2019